RSS

Breath Biopsy

Owlstone Medical, a diagnostics company developing a breathalyser, has been announced as the winner of this year’s (2018) MacRobert Award by the Royal Academy of Engineering. Read more

News

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. Read more

News

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy platform. Read more

News

Diagnostics company, Owlstone Medical, has announced that it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, for its Breath Biopsy platform. Read more

News

Diagnostics company, Owlstone Medical, has announced that GlaxoSmithKline (GSK) will incorporate its Breath Biopsy platform into the clinical development programme of danirixin — a novel GSK pipeline drug candidate for respiratory disease. Read more

Technology

Science museum

Shutterstock.com

Diagnostics company, Owlstone Medical, has revealed that its breathalyser, ReCIVA, has been selected to be featured in the Tomorrow’s World gallery at the Science Museum in London. Read more

Technology

Diagnostics company, Owlstone Medical, and Cancer Research UK (CRUK) have initiated a trial that is focused on the identification of breath biomarkers for the early detection and diagnosis of various cancers. Read more

News

Founder and CEO of Owlstone Medical, Billy Boyle, has been announced as the winner of the Royal Academy of Engineering’s Silver Medal, which recognises his work in the development of the company’s Breath Biopsy platform. Read more

News